If you're looking to add a few growth shares to your portfolio, then you're in luck.
Right now, there are a large number of companies on the Australian share market that are growing their earnings at above-average rates.
Three top growth shares that I would buy today are listed below:
Appen Ltd (ASX: APX)
Appen is a leading developer of high-quality, human annotated datasets for the machine learning and artificial intelligence markets. As high-tech as these markets are, they still require large amounts of training data to build and improve their applications. Thanks to Appen having a +1 million on-demand global crowd that cover 130 countries and 180 languages and dialects, I believe it is well-positioned to benefit greatly from the rapidly growing demand for training data.
Audinate Group Limited (ASX: AD8)
Audinate is a provider of hardware and software solutions to the audio/visual (AV) market. Its key product is the flagship and award-winning Dante media networking solution. This product is the global leader in AV connectivity, eliminating the need for traditional analogue connections. It has been experiencing very strong demand for Dante, which led to it posting a 34% increase in revenue to US$20.3 million in FY 2019. Given the quality of its offering and its sizeable addressable market, I expect similarly strong growth in FY 2020.
CSL Limited (ASX: CSL)
Another top growth share to consider buying is CSL. I'm a big fan of this global biotherapeutics company and believe it is one of the highest quality companies on the ASX. This is due to the quality of its products, its talented management team, and its high level of investment in R&D. Furthermore, the increasing demand for its existing therapies, its expanding plasma collection network, and its pipeline of lucrative products look to have positioned it to continue growing its earnings at a solid rate for many years to come.
